CCL2 and prostate carcinoma: In 2010, Kerr et al. [135] described that murine platelets sequestered functionally active molecules like monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α) in blood collected from a xenograft model injected with human prostate cancer cells.